Sunday, December 11, 2011

Generic Drugs to Boost German Pharma by Shushmul Maheshwari

According to our research report “German Pharma Sector Analysis”, Germany is one of the largest pharmaceutical markets in the world. Most of the pharma companies in Germany concentrate on research, which has led the country to become one of the most advanced pharma markets in the world. Our research indicates that generic drugs are playing a vital role in the growth of the German pharmaceutical industry. The total sales of generic drugs in 2009 were more than two-third of the total pharmaceutical market.

Our extensive research of the German pharmaceutical industry has indicated that the generic drugs market will grow at a CAGR of around 8.3% during 2010-2012. In this segment, we expect the emergence and entry of several global generic majors in near future. This will give impetus to the German pharmaceutical market. Our study shows that most of the growth in the sector will be driven by new and innovative product launches and increasing exports to the Asian and Eastern European market.

Our study also reveals that the future prospects of the sector remain bright and it is expected that the market will continue to post a strong and consistent growth. However, growth in the domestic market is expected to slow down.

Besides, our research report has studied other market drivers which are fuelling growth in the German pharmaceutical market. The report covers the latest market trends at both the company and overall industry levels, which give a clear picture about the current industry scenario. It provides a complete overview of the regulatory environment.

“German Pharma Sector Analysis” provides thoroughly researched information, authentic data and comparable statistics of the German pharmaceutical industry. The report studies industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Overall, the report will prove useful to the clients looking to invest or making joint ventures in the pharmaceutical market.

For FREE SAMPLE of this report visit: